These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 10770996

  • 1. Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically.
    Reuben M, Boye S, Clarke PB.
    Eur J Pharmacol; 2000 Mar 30; 393(1-3):39-49. PubMed ID: 10770996
    [Abstract] [Full Text] [Related]

  • 2. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB, Reuben M.
    Br J Pharmacol; 1996 Feb 30; 117(4):595-606. PubMed ID: 8646402
    [Abstract] [Full Text] [Related]

  • 3. Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes.
    Reuben M, Clarke PB.
    Neuropharmacology; 2000 Jan 04; 39(2):290-9. PubMed ID: 10670424
    [Abstract] [Full Text] [Related]

  • 4. Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release.
    Grilli M, Parodi M, Raiteri M, Marchi M.
    J Neurochem; 2005 Jun 04; 93(5):1353-60. PubMed ID: 15934954
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
    Rao TS, Correa LD, Adams P, Santori EM, Sacaan AI.
    Brain Res; 2003 Nov 14; 990(1-2):203-8. PubMed ID: 14568345
    [Abstract] [Full Text] [Related]

  • 6. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG, Kaiser S, Soliakov L, Marks MJ, Collins AC, Washburn M, Wright E, Spencer JA, Gallagher T, Whiteaker P, Wonnacott S.
    J Neurosci; 2000 Apr 15; 20(8):2783-91. PubMed ID: 10751429
    [Abstract] [Full Text] [Related]

  • 7. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
    Reuben M, Louis M, Clarke PB.
    Br J Pharmacol; 1998 Nov 15; 125(6):1218-27. PubMed ID: 9863650
    [Abstract] [Full Text] [Related]

  • 8. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.
    Sacaan AI, Menzaghi F, Dunlop JL, Correa LD, Whelan KT, Lloyd GK.
    J Pharmacol Exp Ther; 1996 Feb 15; 276(2):509-15. PubMed ID: 8632316
    [Abstract] [Full Text] [Related]

  • 9. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
    Dwoskin LP, Teng L, Buxton ST, Crooks PA.
    J Pharmacol Exp Ther; 1999 Mar 15; 288(3):905-11. PubMed ID: 10027825
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
    Sacaan AI, Dunlop JL, Lloyd GK.
    J Pharmacol Exp Ther; 1995 Jul 15; 274(1):224-30. PubMed ID: 7542334
    [Abstract] [Full Text] [Related]

  • 11. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK, Sumithran SP, Dwoskin LP.
    J Pharmacol Exp Ther; 2002 Sep 15; 302(3):1113-22. PubMed ID: 12183670
    [Abstract] [Full Text] [Related]

  • 12. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
    Azam L, McIntosh JM.
    Mol Pharmacol; 2006 Sep 15; 70(3):967-76. PubMed ID: 16735605
    [Abstract] [Full Text] [Related]

  • 13. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus.
    Sershen H, Balla A, Lajtha A, Vizi ES.
    Neuroscience; 1997 Mar 15; 77(1):121-30. PubMed ID: 9044380
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes.
    Wilkie GI, Hutson P, Sullivan JP, Wonnacott S.
    Neurochem Res; 1996 Sep 15; 21(9):1141-8. PubMed ID: 8897478
    [Abstract] [Full Text] [Related]

  • 16. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum.
    Wonnacott S, Kaiser S, Mogg A, Soliakov L, Jones IW.
    Eur J Pharmacol; 2000 Mar 30; 393(1-3):51-8. PubMed ID: 10770997
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
    Smith AM, Dhawan GK, Zhang Z, Siripurapu KB, Crooks PA, Dwoskin LP.
    Biochem Pharmacol; 2009 Oct 01; 78(7):889-97. PubMed ID: 19631612
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
    Sidhpura N, Redfern P, Wonnacott S.
    Eur J Pharmacol; 2007 Jul 12; 567(1-2):102-9. PubMed ID: 17477919
    [Abstract] [Full Text] [Related]

  • 20. Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes.
    Miller DK, Crooks PA, Dwoskin LP.
    Neuropharmacology; 2000 Oct 12; 39(13):2654-62. PubMed ID: 11044735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.